Whalegun
Home

Myriad Genetics MYGN spent $290K on lobbying in Q4 2023 · Medicare, Medical

Trade details

Type
Lobbying report
Amount
$290,000
Quarter
Q4 2023
Stock
Myriad Genetics MYGN
Client
Myriad Genetics
Reported
24/01/22

Up 38.1% from last quarter

What else happened in Myriad Genetics around then

Filed or reported within 30 days of the trade day · 23/12/01~24/01/30

Myriad Genetics's other lobbying reports

  • Myriad Genetics

    LobbyingMyriad Genetics

    $40K

    Reported 07/20

  • Myriad Genetics

    LobbyingMyriad Genetics

    Under $5,000

    Reported 07/20

  • Myriad Genetics

    LobbyingMyriad Genetics

    $40K

    Reported 07/18

  • Myriad Genetics

    LobbyingMyriad Genetics

    $30K

    Reported 07/17

  • Myriad Genetics

    LobbyingMyriad Genetics

    $10K

    Reported 07/03